Tirzepatide 40mg
Original price was: £110.00.£98.90Current price is: £98.90.
-
Each vial contains Tirzepatide 40mg, an advanced dual agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is primarily studied for its powerful effects on blood glucose regulation, weight reduction, and metabolic enhancement. Tirzepatide works by stimulating insulin secretion, improving glucose metabolism, reducing appetite, and delaying gastric emptying. The higher 40mg concentration delivers enhanced metabolic benefits, promoting greater fat loss, improved insulin sensitivity, and balanced energy utilization — making it a key peptide for advanced metabolic research.
Description
- Each vial contains Tirzepatide 40mg, a dual GIP and GLP-1 receptor agonist designed to improve blood glucose regulation and promote weight loss. Tirzepatide mimics the effects of two natural incretin hormones — glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) — to enhance insulin secretion, reduce appetite, and slow gastric emptying. This combination supports better metabolic control and sustained fat reduction.
Tirzepatide is a breakthrough peptide that targets both GLP-1 and GIP receptors, offering a dual-action approach for weight management and Type 2 Diabetes treatment. It helps regulate appetite, stabilize blood sugar levels, and improve insulin sensitivity, making it a powerful option in modern metabolic therapy.
Supports significant weight loss through appetite control and fat reduction
Improves insulin sensitivity and blood glucose regulation
Lowers HbA1c levels in diabetic patients
Promotes a prolonged feeling of fullness and satiety
Enhances metabolic health and may reduce cardiovascular risks
Tirzepatide works through dual receptor activation, targeting both GIP and GLP-1 pathways to optimize metabolic function. Its mechanisms include:
Stimulating insulin release in response to elevated glucose levels
Suppressing glucagon secretion, which helps lower blood sugar
Delaying gastric emptying to promote fullness and reduce appetite
Enhancing lipid metabolism, contributing to improved overall energy balance
Tirzepatide represents a next-generation metabolic therapy, combining the benefits of two incretin pathways into a single molecule. Through its multifaceted effects on glucose control, appetite, and energy balance, it shows promising potential for supporting metabolic health, weight management, and overall wellness.
- Intended for laboratory research purposes only
- Not for human use or consumption
- Check local laws and regulations before ordering or handling
Additional information
| Brand |
KLÖBER |
|---|
Reviews
There are no reviews yet.